Kenji Kabashima

97PUBLICATIONS
269CO-AUTHORS
Innate immunityAllergyMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (97)

|Jul 14, 2026
Cytotoxic CD4+ T cells across aging: a conceptual framework for health, protection, pathology, and age-associated diseases.

|Jul 11, 2026
The CCL20-CCR6 axis predominantly drives IL-17-mediated psoriasis while modestly contributing to papain-induced type 2 inflammation.

|Jun 04, 2026
Atopic dermatitis.

|May 26, 2026
From legacy subsets to auditable descriptors: implementing the 2025 T-cell nomenclature guidelines for inflammatory skin diseases.

|May 21, 2026
Sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis.

|Nov 23, 2025
Targeting fibroblast derived thrombospondin 2 disrupts an immune-exclusionary environment at the tumor front in colorectal cancer.

Kosuke Iwane, Yuki Nakanishi, Yu Muta

Pageof 17

Frequent Collaborators

17 joint publications

Takashi Nomura

15 joint publications

Saeko Nakajima

12 joint publications

Naotomo Kambe

12 joint publications

Toshiaki Kogame